Control Of High Blood Pressure Research Articles

Challenges and strategies for hypertension management: qualitative analysis of small primary care practices with varying blood pressure control.

Electronic health record (EHR) data on blood pressure (BP) control among patients with hypertension show that practices' rates vary greatly. This suggests providers use different approaches in managing hypertension, and so we aimed to explore challenges small primary care practice providers face and strategies they use to manage patients' BP. We explored differences between providers with high and low BP control rates to help inform future quality improvement work. In 2015, we recruited practices in New York City with five or fewer providers. We employed a stratified purposeful sampling method, using EHR data to categorize small practices into groups based on the proportion of patients with hypertension whose last BP was <140/90: high control (>= 80%), average control (60-80%) and low control (<60%). We conducted semi-structured qualitative interviews with clinicians from 23 practices-7 high control, 10 average control and 6 low control-regarding hypertension management. We used a combined inductive/deductive approach to identify key themes, and these themes guided a comparison of high and low BP control providers. Small practice providers reported treatment non-adherence as one of the primary challenges in managing patients' hypertension, and described using patient education, relationship building and self-management tools to address this issue. Providers differed qualitatively in the way they described using these strategies; high BP control providers described more actively engaging and listening to patients than low control providers did. How providers communicate with patients may impact outcomes-future quality improvement initiatives should consider trainings to improve patient-provider communication.

Lifestyle counselling and behavioural change: role among adult hypertensives in a rural tertiary institution

Background: In spite of the availability of myriads of antihypertensive medications, the control of high blood pressure is still low. Studies on effect of lifestyle behavioural changes through coun...

Abstract WP480: Stroke Risk Among Post-menopausal Breast-cancer Survivors

Background and Purpose: Cancer is a well-known risk factor for stroke, yet whether the stroke comorbid with a cancer or the risk further increases along with a long-term survivorship is unclear. Also, whether the stage of cancer and receiving hormonal therapy affect stroke risk particularly in post-menopausal breast cancer survivors (BCS) is yet to be determined. This study aimed to (1) identify comorbid stroke risks at the time of the cancer diagnosis; (2) examine the changes of stroke risk at one, five and ten years after survival; and (3) explore relationships between demographic and cancer-related factors and stroke risks among BCS. Methods: We retrieved 4,152 deidentified BCS data from a Massey Cancer Registry. After excluding 39 pre-existing stroke and selecting who met the Framingham Stroke Risk Score (FSRS) criteria, we included 2141 (mean age of 64.22; SD=7.30 years). Among them, 616 who had all components for the FSRS equation (age, sex, systolic blood pressure, presence of cardiovascular disease, left ventricular hypertrophy, smoking, atrial fibrillation, and presence of diabetes) were included in this analysis. Results: We found that (1) comorbid stroke risk at the time of the diagnosis was 10.6 in terms of the FSRS; among individual risk factors, elevated systolic blood pressure (SBP&gt;140mmHg, 43.3 %) was prominent followed by the presence of cardiovascular disease markers (39.56%) and diabetes (23.11%). (2) The FSRS consistently increased overtime with the largest increase during the first year of survival (10.60 at baseline vs. 16.07, 17.27. and 17.76 at year 1, 5, and 10, respectively). (3) The FSRS was significantly higher in Non-Hispanic Black than Non-Hispanic White (12.55 vs. 9.25, p=0.016 ) across time. Those who received hormonal therapy showed higher FSRS than those who did not (15.88 vs. 8.17, p=0.000 ); tumor stage was not associated with the FSRS. Conclusion: Stroke risk consistently increase along with the survivorship of a breast cancer, particularly among women after their menopause. Prevention and control of high blood pressure and diabetes should be a target of intervention to reduce the stroke risk among post-menopausal breast cancer survivors.

Prevalence, Awareness and Control of High Blood Pressure in a Semi-Urban Area of Cameroon: An Analysis of May Measurement Month 2019 Screening Results

Background: High blood pressure (HBP) is a global health crisis. More than one billion people in the world suffer from HBP and most of them live in low and middle income countries where the prevalence is increasing. Un-awareness, low treatment and control rates are the main barriers to the fight against this disease and the associated cardiovascular disease risk. Aims: To highlight the importance of measuring blood pressure and identify and reduce the blood pressure (BP) of those who require an intervention to lower their BP according to current guidelines. Methods: This was a cross-sectional study. A HBP screening was organized in two market places and at the district hospital of a semi-urban area in Cameroon during three days—from the 28th to the 30th May 2019. We included all people aged at least 18 years and who accepted to take part to the study. We used a predesigned form and electronic blood pressure machines for the screening. HBP was defined as having a BP ≥ 140/90 mmHg or taking antihypertensive medications. All statistical analysis were done using IBM SPSS version 20.0. Results: We included 200 people in the study. Women were more represented in our sample (57.5%) and the median age was 40 years [30 - 51]. More than a third of the participants had not taken their BP in the past year and 16% of them had never measured their BP. HBP was detected in 49 (24.5%) people among whom 25 (51.0%) were aware of their condition. Among those who were aware they had HBP, 17 (68.0%) were taking antihypertensive medications and as a single drug regimen in most cases (64.7%). BP was controlled in 9/17 (52.9%) people. Conclusion: Nearly one quarter of people living in semi-urban area in Cameroon has HBP. We have found in this area a high rate of unawareness and undertreatment of HBP.

Unhealthy Behaviors, Prevention Measures, and Neighborhood Cardiovascular Health: A Machine Learning Approach.

This study identifies and ranks predictors of cardiovascular health at the neighborhood level in the United States. We merged the 500 Cities Data and the 2011-2015 American Community Survey to create a new data set that includes sociodemographic characteristics, health behaviors, prevention measures, and cardiovascular health outcomes for more than 28 000 census tracts in the United States. We used random forest to rank predictors of coronary heart disease and stroke. For coronary heart disease, the top 5 ordered predictors were the prevalence of taking medicine for high blood pressure control, binge drinking, being aged 65 years or older, lack of leisure-time physical activity, and obesity. For stroke, the top 5 ordered predictors were the prevalence of obesity, lack of leisure-time physical activity, taking medicine for high blood pressure, being black, and binge drinking. Machine learning approaches have the potential to inform policy makers on important resource allocation decisions at the neighborhood level.

Specific hypertension smartphone application to improve medication adherence in hypertension: a cluster-randomized trial

Introduction: Digital interventions, such as smartphone applications (apps), are becoming an increasingly common way to support medication adherence and self-management in chronic illness.Aim: To evaluate the effectiveness of the intervention in pharmacological therapeutic adherence in mild to moderate arterial hypertension (AHT), through an app installed on a mobile phone, as well as the degree of control reached by the patient with this tool.Methods: Prospective, randomized controlled trial, full study and multicenter study. Four primary care centers participated. One hundred and fifty-four hypertensive patients under antihypertensive treatment were included. Two groups were established: a control group (CG) with usual intervention (n = 77) and an intervention group (n = 77) (IG), targeting hypertensive people who owned and regularly used a mobile smartphone, specifically using the app called AlerHTA to promote health education and reminder of appointments. There were three visits: initial, 6 and 12 months. Drug adherence was measured by electronic monitors (MEMSs). The primary outcomes were average daily percentage adherence between 80 and 100%, and AHT control.Results: A total of 148 patients finished the study. Mean age was 57.5 ± 9.9. Global adherence was 77.02% (CI = 70.25–83.79) and daily adherence was 74.32% (CI = 67.29–81.35%). Daily adherence was 93.15% and 86.3% in IG, and 70.66% and 62.66% in CG after 6 and 12 months respectively (p < .05). The percentage of uncontrolled patients was 28.3% (CI = 21.05–35.55%). The control of high blood pressure at 12 months was 17.8% and 38.6% for IG and CG respectively (p < .05). The number of patients needed to treat to avoid non-adherence (NNT) was 4.23 patients.Conclusions: The intervention with an app installed on the mobile phones of hypertensive patients favors pharmacological therapeutic adherence and improves the percentage of hypertensive patient control.Trial registration: Spanish Agency of Medicine: EPA-SP UN-HTA-2015-01.

Psychosocial Stressors at Work and Ambulatory Blood Pressure.

Psychosocial stressors at work from the demand-latitude and effort-reward imbalance models are adverse exposures affecting about 20-25% of workers in industrialized countries. This review aims to summarize evidence on the effect of these stressors on blood pressure (BP). Three systematic reviews have recently documented the effect of these psychosocial stressors at work on BP. Among exposed workers, statistically significant BP increases ranging from 1.5 to 11mmHg have been observed in prospective studies using ambulatory BP (ABP). Recent studies using ABP have shown a deleterious effect of these psychosocial stressors at work on masked hypertension as well as on blood pressure control in pharmacologically treated patients. Evidence on the effect of these psychosocial stressors on BP supports the relevance to tackle these upstream factors for primary prevention and to reduce the burden of poor BP control. There is a need for increased public health and clinical awareness of the occupational etiology of high BP, hypertension, and poor BP control.

A11742 Continous improvement of treatable cardiovascular risk factors control in secondary prevention of established coronary heart disease.

Objectives: In established CHD the prevention guidelines recommend random hypolipidemic treatment and control of blood pressure. However, even stronger mortality risk may present diabetes and even prediabetes. We analysed, how standing reccommendations are followed. Methods: Analysis of five independent surveys of patiens with stabilized manifest CHD performed in 1995 - 2017 (Czech samples of EUROASPIRE I, II, III, IV and V surveys), pts interviewed at least 6 months after hospitalization for acute coronary syndrome and/or revascularization). Results: 2098 pts investigated. 1995–2017 systolic BP decreased from144.1 to 132.5 mmHg (p < 0.001), diastolic BP from 87.5 to 80.3 mmHg (p < 0.001). Control of hypertension improved from 45 to 86%. Use of betablockers increased from 65.2 to 88.1%, of ACEI /sartans from 28.0 to 85.6%. Total cholesterol decreased from 5.41 to 4. 33 mmol/l (p < 0.0001), LDL cholesterol from 3.4 to 2.34 mmol/l (p < 0.0001). Hypolipidaemic drugs were used in 28.7% in 1995 and in 95.1% in 2017, statins in7.3 and 94.6 % respectively. Prevalence of diabetes (fasting glycaemia > 7 mmol/L or use of antidiabetic treatment) increased from 26% to53%. Diabetes carries in these patients, according to our follow up data, considerably higher mortality risk than elevated blood pressure or hypercholesterolaemia. Conclusion: Despite progress in control of high blood pressure and hypercholesteroleemia in patients with established CHD, prevalence of diabetes is increasing and diabetes carries higher mortality risk than elevated blood pressure or hypercholesterolemia

The Telemedicine applied to the follow up of patients with End Stage Renal Failure

Abstract&#x0D; In the 21st century, renal failure is a chronic disease that affects several millions people in France and around 600 millions worldwide. Its prevalence in the general population increases with the lengthening of the life expectancy that characterizes the developed countries and which begins to appear in the developing countries. Chronic hemodialysis is a treatment that saved many children and young adults in the 20th century whose kidneys were destroyed by several infectious and toxic agents and by untreated malignant hypertension. These causes have been controlled by hygiene measures, anti-infective agents or protective pharmacological agents of the cardiovascular system. Today the causes of end stage renal failure are dominated by degenerative diseases due to aging, such as diabetes and chronic vascular disease. The prevention of the worsening of chronic renal failure is now possible due to better control of high blood pressure and diabetes which are the two main causes of kidney destruction. Hemodialysis treatment cannot always be relayed by renal transplantation. Many patients remain on chronic hemodialysis until they die. It is important to adapt the conditions of treatment to the social life of patients affected by this chronic disease so that these are the best possible. This is the goal of telemedicine that allows to remotely monitor the main clinical and biological factors associated with the worsening of the disease. Teledialysis (hemodialysis and peritoneal dialysis) allows to perform dialysis sessions at home or at the nearest in home substitutes (nursing home) or in satellite units of hemodialysis. Similarly, when the patient is transplanted, it makes possible to either lighten or intensify the surveillance according to the risk or not of graft rejection through home teleconsultation.The tools of the digital era such as telemedicine, health connected with connected objects and mobile apps for medical purposes, the performance of which is increasing with the algorithms of artificial intelligence (machine learning, deep learning), can improve the relationship between the patient and his doctor. An ethical reflection must be associated with all these innovations. New exercise of the medicine will be greatly enriched due to medical time more devoted to the relationship with the patient. The new care organizations made possible by digital technologies must be taught to the new generations of nephrologists.&#x0D;

Study of essential hypertension with special reference to end organ damage in adults

Background: Hypertension, a major public health concern, affecting 20-25% of the adult population. It is the major risk factor for diseases involving Cardio Vascular (CV) and renalsystem. The World Health Organization (WHO) has estimated that high Blood Pressure (BP) causes 1 in every 8 deaths, making hypertension the third leading killer in the world. The recent emerging trend in the treatment of hypertension is not only based on the pragmatic need to lower BP levels, but also on lowering the CV risk profile, which is largely linked to the presence of the end organ damage.Methods: One hundred patients with hypertension are recruited in this study. The ethics committee of Rangaraya Medical College, Kakinada approved this study and all the participants provided informed consent for all the procedures in the study protocol.Results: Majority of the patients (40%) with EOD have hypertension of &gt;10 years duration. The relative frequency of various end organ damages (CVS: 34%, CNS: 17%, kidney: 12% and eye: 10%) is also high in patients with hypertension of &gt;10 years duration.Conclusions: A significant proportion of hypertensive subjects had documented associated EOD, with LVH being the most prevalent EOD. The above findings emphasize the important role of the primary care clinicians to the early detection, treatment and control of high blood pressure that might help to reducing overall cardiovascular risk.

Exercising in Stressful Environmental Conditions with Hypertension Versus Normal Blood Pressure

ABSTRACTHypertension (high blood pressure [BP]) is the most common, costly, and preventable cardiovascular disease risk factor in the world. Regular aerobic exercise is universally recommended as a lifestyle therapeutic intervention for the prevention, treatment, and control of high blood pressure. However, the stressor response to exercise in extreme but commonly experienced stressful environments may be exacerbated in individuals with hypertension, a situation not fully described in the literature. Therefore, we performed a systematic search examining the potential adverse health effects of exercising in hot, humid, cold, or air-polluted environments among adults with hypertension. Studies included adults with hypertension compared to normal BP and that with at least one physiological marker in response to heat, humidity, cold, windchill, or air pollution. The present systematic review revealed few studies that explored differences between individuals with hypertension and normal BP while exercising in commonly experienced stressful environmental conditions. Our preliminary evidence suggests that adults with hypertension may be more vulnerable to adverse cardiovascular stressor responses while exercising in the heat. Future studies are required to better characterize these maladaptive responses to extreme heat or humidity to better identify potential counter-measures for this vulnerable population.

High Blood Pressure prevention and control: from evidence to action

The Pan American Health Organization (PAHO) with the World Hypertension League has established the 17th May to promote the prevention and control of High Blood Pressure (HBP). Currently nearly 1.13 billion of adults suffer from HBP (blood pressure ≥140/90 mm Hg) worldwide. While HBP prevalence decreased in high income countries (HIC) between 1975 and 2015, the opposite trend was observed in low- and middle- income countries (LMIC). Particularly, in Latin American and Caribbean countries the prevalence decreased from 40.6% to 26.8% and from 26.8% to 19.4% for men and women between 45 to 49 years old respectively. However, in 2015, HBP accounted for 8.9 of the total of disability adjusted life years (DALYS) and was associated with 4.9 million, 2.0 million and 1.5 million deaths due to ischemic heart disease, hemorrhagic stroke and ischemic stroke respectively. Therefore, HBP is the leading cardiovascular risk factor worldwide. In Colombia, the last National Health Survey reported a global prevalence of 22.8% and nearly 60% for those between 60 and 69 years in 2007

Аналіз і перспективи нових клінічних рекомендацій ААР (2017) скринінгу і контролю високого артеріального тиску у дітей та підлітків

Аналіз і перспективи нових клінічних рекомендацій ААР (2017) скринінгу і контролю високого артеріального тиску у дітей та підлітків

Global Implications of Blood Pressure Thresholds and Targets: Guideline Conversations From the World Hypertension League.

See related article, pp e13–e115 Global high blood pressure control and prevention is a major goal of the World Hypertension League (WHL), which strives to support and promote population strategies for the reduction in risks of hypertension-related outcomes. The implementation of hypertension management protocols and recommendations based on evidence from clinical studies is associated with the risk reduction in stroke, as well as cardiovascular and renal disease.1 The impact of the structured hypertension guidelines can be seen in the Figure where the risks of elevated blood pressure identified in the 1920s and the benefit of blood pressure reduction from the Veterans Administration studies was associated with declines in population stroke mortality.2–5 As evidence in the Table, the decline in stroke mortality coincides with the reduction of population blood pressure pressures which was consistent with the lowered blood pressure thresholds and targets described in the sequential recommendations from the Guidelines.6–12 View this table: Table. Mean and 90th …

Short‐term captopril treatment causes persistently decreased blood pressure associated with long‐lasting shifts in gut microbiota and improvement in gut pathology

IntroductionAngiotensin‐converting enzyme inhibitors such as captopril (CAP), are widely used and preferred treatment option for high blood pressure (BP) control. It has been shown that only ~30% of orally administrated CAP is absorbed by the rat intestine. Increasing importance of gut microbiota in drug metabolism coupled with dysbiosis linked to high BP has raised interesting questions regarding the role of gut microbial community in drug‐resistant hypertension. In addition, previous studies found sustained effects of CAP on BP after withdrawal of CAP in spontaneously hypertensive rats (SHR). Thus, our objective was to test the effects of CAP on gut microbiota and whether any alteration in gut microbiota and pathology is preserved after withdrawal of CAP, which may be involved in the maintenance of lowered BP.MethodsMale normotensive Wistar Kyoto (WKY) and SHR were kept either with or without CAP (250mg/day/kg) in the drinking water for 4 weeks, and then all rats were placed on regular water until week 16. BP was measured by tail cuff on week 3 (CAP ON) and week 6 (CAP OFF). Fecal microbiota collected on week 4 (CAP ON) and week 8 (CAP OFF) was analyzed. Intestinal morphology was evaluated at week 16.ResultsCAP treatment for 4 weeks altered gut microbial composition in WKY and SHR, and the altered gut microbiota was preserved 4 weeks after CAP withdrawal, characterized by aggregated clusters of CAP ON and CAP OFF groups for both WKY and SHR in principal coordinate analysis. Microbial richness was significantly increased in SHR in the presence of CAP for 4 weeks (control: 6386±514.6 vs CAP ON: 8637±271.8, P=0.0014), and maintained a trend to be increased at 8 weeks (control: 6386±514.6 vs CAP OFF: 7601±355.5, P=0.0688). Intestine H&amp;E staining demonstrated significant and sustained improvement in the fibrotic area (control: 12.98±0.81% vs CAP OFF: 10.23±0.69%, P=0.036), goblet cell number (control: 39±3.57 cells/villi vs CAP OFF: 65±5.29 cells/villi, P=0.0006) and villi length (control: 271.4±9.85 μm vs CAP OFF: 388.8±12.29 μm, P&lt;0.0001) in the SHR 12 weeks post‐withdrawal of CAP. In line with microbial and intestinal changes, a significant decrease in systolic BP was observed in the CAP‐treated SHR (control: 166.8±7.1 mmHg vs CAP ON: 107.0±5.4 mmHg, P&lt;0.0001). After withdrawal of CAP, the reduction in systolic BP in CAP‐treated SHR (control: 208.8±3.5 mmHg vs CAP OFF: 182.2±9.5 mmHg, P=0.03) was sustained.ConclusionOral administration of CAP significantly improved gut microbiota and pathology in SHR. Persistent reduction in BP during and post‐withdrawal of CAP was associated with sustained gut microbial alterations and pathological improvement, indicating potential contribution of gut microbiota in the CAP‐mediated reduction in BP.Support or Funding InformationU.S. Department of Health &amp; Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) ‐ 5R01HL033610‐32 [Raizada]U.S. Department of Health &amp; Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) ‐ 5R01HL132448‐02 [Raizada]This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Healthy Living: Changing your lifestyle to improve your blood pressure

Most people know that high blood pressure can often be improved by making smart dietary choices and choosing foods lower in sodium. But did you know there are other ways to help control high blood pressure and even prevent it? This 4-page fact sheet is a major revision that discusses four lifestyle changes that can help you keep blood pressure down. Written by Karla P. Shelnutt and Linda B. Bobroff, and published by the UF/IFAS Department of Family, Youth and Community Sciences, revised February 2018. http://edis.ifas.ufl.edu/fy1129

Implications of Recent Clinical Trials and Hypertension Guidelines on Stroke and Future Cerebrovascular Research.

The decline in stroke mortality observed over the past 50 years has been attributed, in part, to improved implementation of high blood pressure (BP) treatment and control strategies based on the most current evidence from clinical research studies and randomized controlled trials (RCTs).1 The reduction in stroke risks coincides with the shift to lower systolic BP (SBP) distributions in the US adult population for all age groups.1 However, critical clinical questions remain about the treatment, control, and prevention of high BP. New evidence from RCTs and meta-analyses2–6 is expected to have an important positive impact on hypertension guidelines, clinical practice, and future research. Because stroke risk is substantially associated with BP levels and hypertension treatment and control, raised BP and stroke reduction is so heavily tied to BP control, stroke prevention is a key driving force for clinical practice decisions. As a component of the 2017 International Stroke Conference, the American Heart Association, American Stroke Association, and World Hypertension League cosponsored session focused on impact of recent hypertension studies, meta-analyses and new clinical guidelines on stroke risk reduction, and implications for future research. The Prospective Studies Collaboration7 showed a log-linear relationship between BP and stroke declining with lower BP values right down to <120 mm Hg systolic and <70 mm Hg diastolic. Further, a meta-analysis of 147 RCTs of antihypertensive therapy the percentage reduction in stroke with BP reduction down to a mean of 110/70 mm Hg regardless of their BP before treatment.8 Another systematic review in patients with diabetes mellitus reported a decrease of 13% in the risk of stroke for each 5 mm Hg reduction in SBP, and by 11.5% for each 2 mm Hg reduction in diastolic BP.9 In another meta-analysis of 123 studies, Ettehad et al4 provided support for lowering SBP to …

Nutritional Considerations for Dialysis Vegetarian Patients, Part One

Nutritional Considerations for Dialysis Vegetarian Patients, Part One

The burden, management rates and influencing factors of high blood pressure in a Chinese rural population: the Rural Diabetes, Obesity and Lifestyle (RuralDiab) study.

The aim of the present study was to examine the prevalence, awareness, treatment, control, and potentially influencing factors of high blood pressure (HBP) in Chinese rural adults based on a cross-sectional study. Using data from the Rural Diabetes, Obesity and Lifestyle (RuralDiab) study, a total of 30,834 participants aged 18-74 years were enrolled for the epidemiological study. The multivariate logistic regression model including all selected potentially influencing factors was carried out for the adjusted odds ratios (ORs) and 95% confidence intervals (CIs). Overall, a total of 9872 individuals were diagnosed as HBP (32.02%) with substantial imparity between men and women (32.87% vs. 30.58%), and the corresponding age-standardized prevalence of HBP were 19.50% (20.94% in men and 18.85% in women). Among the HBP patients, 6654 were aware of the diagnosis (67.40%), 5391 were taking medication (54.61%), and 2572 had their blood pressure controlled (26.05%).The corresponding age-adjusted awareness, treatment, and control of HBP were 59.35%, 45.91%, and 23.87%, respectively, and the corresponding rates were higher in women than those in men. The age-specific prevalence and management rates of HBP displayed increased trends with aging in both sexes(P trend < 0.05). Aging, low level of education, unhealthy lifestyle, positive family history of hypertension, overweight, obesity, diabetes, and dyslipidemia were associated with the prevalence, awareness, treatment, and control of HBP. In conclusion, uncontrolled HBP was common with high prevalence in Chinese rural residents. Strengthening the primary prevention through lifestyle modifications is necessary for reducing the disease burden and improving the management rates of HBP.

Effects of home telemonitoring on the control of high blood pressure: a randomised control trial in the Fangzhuang Community Health Center, Beijing.

This study aimed to evaluate the effect of home telemonitoring on the control of high blood pressure in the Fangzhuang Community Health Center in Fengtai District, Beijing. A total of 110 hypertensive patients with uncontrolled high blood pressure were equally allocated to an intervention group and a control group randomly. The participants in the intervention group received home telemonitoring for blood pressure delivered by a team comprising a GP, a hypertension specialist, a general nurse and an information manager. The participants in the control group received the usual care. The levels of systolic and diabolic blood pressure of the participants were assessed on days 0 (baseline), 30, 90 and 180. On average, the intervention group had a greater reduction in blood pressure compared with the control by 6.6-8.0mmHg in systolic blood pressure and 0-3.0mmHg in diastolic blood pressure. Similarly, higher proportions of patients with normal blood pressure were achieved in the intervention group (63.6-71.2%) compared with the control (38.5-41.8%). The reduction in systolic blood pressure for the participants in the intervention group was positively correlated with the utilisation of the app (P<0.05). Home telemonitoring is effective in the control of high blood pressure.